title: Effects of colchicine on IgE-mediated early and late airway reactions.
abstract: BACKGROUND
  The pathogenesis of bronchial asthma is thought to involve elements of both acute and chronic inflammation. Hence, there is growing interest in the potential of immunomodulatory drugs in asthma therapy. This study examines the effects of the anti-inflammatory compound colchicine on early and late allergen-induced, IgE-mediated airway reactions.
  
  
  METHODS
  Nine mildly allergic asthmatic subjects were evaluated in a single-blind, two-way crossover study designed to examine the effects of colchicine and placebo on early and late airway reactions to ragweed allergen and related changes in nonspecific responsiveness to methacholine.
  
  
  RESULTS
  Compared with placebo, colchicine provided 19% (p = 0.036) and 40% (p = 0.004) inhibition of early and late airway reactions to allergen, respectively. Allergen-induced increases in methacholine responsiveness were observed with both types of treatment, although there was a trend toward a smaller increase after administration of colchicine (p = 0.13). We also found that methacholine responsiveness per se was not directly altered by colchicine (n = 7). In 6 subjects, we found suppression of neutrophil leukotriene B4 generation after colchicine treatment, suggesting that the colchicine dose (0.6 mg twice daily) was sufficient to produce an anti-inflammatory effect. Further in vitro studies using purified human lung tissue mast cells failed to demonstrate inhibition of mediator release at concentrations corresponding to achievable tissue or blood levels during the in vivo trial.
  
  
  CONCLUSIONS
  Colchicine partially inhibits IgE-mediated early and late airway reactions at conventional clinical doses. This inhibitory effect may be mediated via suppression of some cell species other than the lung tissue mast cell. Controlled studies to examine the benefits of colchicine in clinically evidenced asthma are warranted.
authors.affiliation: Department of Medicine, Jefferson Medical College, Philadelphia, PA, USA.
authors.forename: S J
authors.initials: SJ
authors.lastname: Kelly
authors.forename: A J
authors.initials: AJ
authors.lastname: Uri
authors.forename: H S
authors.initials: HS
authors.lastname: Freeland
authors.forename: E J
authors.initials: EJ
authors.lastname: Woods
authors.forename: E S
authors.initials: ES
authors.lastname: Schulman
authors.forename: S P
authors.initials: SP
authors.lastname: Peters
authors.forename: J E
authors.initials: JE
authors.lastname: Fish
mesh_terms: D000328:Adult; D001249:Asthma / Q000188:drug therapy* / Q000503:physiopathology*; D001980:Bronchi / Q000187:drug effects*; D001985:Bronchial Provocation Tests; D003078:Colchicine / Q000494:pharmacology* / Q000627:therapeutic use*; D018592:Cross-Over Studies; D005260:Female; D006636:Histamine Release / Q000187:drug effects; D006801:Humans; D007073:Immunoglobulin E / Q000502:physiology; D008168:Lung / Q000166:cytology; D008297:Male; D008407:Mast Cells / Q000187:drug effects / Q000378:metabolism; D009504:Neutrophils / Q000502:physiology; D016037:Single-Blind Method
chemical_list: D007073:Immunoglobulin E; D003078:Colchicine